Similar Articles
Patient Management in Neurology Intensive Care During COVID-19 Pandemic Period
Fergane Memmedova, Semra Arı Sevingil, Fatma Altuntaş Kaya, Fatma Ger Akarsu, Zaur Mehdiyev, Ulviyyat Jafarova, Özlem Aykaç, Atilla Özcan Özdemir
DOI: 10.4274/tnd.2022.43420
Generalized Myasthenia Gravis Diagnosed After Blepharoplasty
Murat Alemdar, Mustafa Karabacak
DOI: 10.4274/tnd.2021.56313
Presence of Concomitant Depression and its Effect on Clinical Course in Patients Diagnosed with Myasthenia Gravis
Fatma Ece Çetin, Hatice Karasoy
DOI: 10.4274/tnd.2021.76735
Demographic, Clinical, Electrophysiological, and Immunological Features of Patients with Myasthenia Gravis Diagnosed in the Last Five Years
Recep Yevgi
DOI: 10.4274/tnd.2021.45389
Bilateral Internuclear Ophthalmoplegia in Myasthenia Graves
Gülhan Sarıçam, Ebru Bilge Dirik, Şener Akyol, Ömer Anlar
DOI: 10.4274/tnd.78989
Effect of Thymectomy in Myasthenia Gravis
Tuncay Gündüz
DOI: 10.4274/tnd.09581
Myasthenia Gravis after Botulinum Toxin Type A Injection
Hacer Durmuş Tekçe, Feza Deymeer, Piraye Oflazer Serdaroğlu, Yeşim Parman
DOI: 10.4274/tnd.02703
HLA and Acetylcholine Receptor Antibody Relationship in Myastenia Gravis Patients
İrem Fatma Aşan, Ufuk Şener, Pınar Bekdik, Işıl Çoker, Yaşar Zorlu
lnvestigation Of Antibody Dependent Cell Mediated Cytotoxicitiy Levels in Myasthenia Gravis
Serap ÖZER, Berril DÖNMEZ, Özden ÜLKER, Murat SAYAN, Hakkı BAHAR, Ahmet GENÇ, Egemen İDİMAN
Late-onset Myasthenia Gravis
C. YÜCESAN, D. TUNCEL, N. YÜCEMEN, N. MUTLUER
Investigation of Thymus In Myasthenia Gravis
Muhteşem GEDİZLİOĞLU, Zehra ADIBELLİ, C. Ahmet KULAN, R. Reha BİLGİN, Pınar ÇE